Sp427
GUT MICROBIOME AS A DETERMINANT OF TREATMENT RESPONSE IN IBD
Date
May 7, 2023
Explore related products in the following collection:
Tracks
Related Products
PLACEHOLDER
Switching from originator to biosimilar infliximab (IFX) is effective and safe. However, data on multiple switching are scarce. The Edinburgh IBD unit has undertaken three switch programmes: (1) Remicade to CT-P13 (2016), (2) CT-P13 to SB2 (2020), and (3) SB2 to CT-P13 (2021)…
THE ROLE OF THE GUT MICROBIOME IN THE ASSOCIATION BETWEEN CITRUS FRUIT AND THE RISK OF DEPRESSION
BACKGROUND: Diet is known to alter the risk of depression. Increasing data also demonstrate a causal role of the gut microbiome in mental illness, via the gut-brain axis. However, it remains unclear how diet and the microbiome mechanistically influence depression risk in humans…
AN EMPIRICAL DIETARY PATTERN ASSOCIATED WITH GUT MICROBIAL FEATURES IN RELATION TO COLORECTAL CANCER RISK
BACKGROUND AND AIMS: Chemoresistance is a major cause of colorectal cancer (CRC) recurrence and death. The critical role of gut microbiome in the efficacy of CRC chemotherapy remains unclear…
INTRODUCTION
SOCIETY: AGA